Cargando…
Deregulation of apolipoprotein C2 gene in cancer: A potential metabolic vulnerability
Autores principales: | Liu, Yuqiao, Meng, Yiting, Zhang, Tian, Alachkar, Houda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161511/ https://www.ncbi.nlm.nih.gov/pubmed/34185418 http://dx.doi.org/10.1002/ctm2.406 |
Ejemplares similares
-
Response to ‘comment on rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing’ by Davydov A.N.; Bolotin D.A.; Poslavsky S. V. and Chudakov D.M.
por: Huang, Yu-Ning, et al.
Publicado: (2023) -
Gene enhancer deregulation and epigenetic vulnerability
por: Lu, Rui, et al.
Publicado: (2016) -
Reply: Comment on ‘The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis'
por: Lajin, B, et al.
Publicado: (2014) -
Reply to ‘Comment on: The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis'
por: Lajin, B, et al.
Publicado: (2014) -
Metabolic subtype reveals potential therapeutic vulnerability in acute promyelocytic leukaemia
por: Sung, Ji‐Yong, et al.
Publicado: (2022)